Bloomage BioTechnology Corporation Limited (688363.SS) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-26). See the full ratio breakdown and business-activity screen below for the reasoning.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. 688363.SS files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.09% | 30.00% | Pass |
| Interest-bearing investments | 5.65% | 30.00% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 4.38% | 33.00% | Pass |
| Interest-bearing investments | 11.83% | 33.00% | Pass |
| Non-liquid assets | 81.68% | at least 20.00% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 4.38% | 33.33% | Pass |
| Cash + interest-bearing securities | 11.83% | 33.33% | Pass |
| Accounts receivable | 18.32% | 33.33% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 4.38% | 33.33% | Pass |
| Cash + interest-bearing securities | 11.83% | 33.33% | Pass |
| Accounts receivable | 18.32% | 50.00% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.49% | 33.00% | Pass |
| Cash + interest-bearing securities | 4.03% | 33.00% | Pass |
| Accounts receivable | 2.21% | 33.00% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.32% | 33.00% | Pass |
| Cash + interest-bearing securities | 3.55% | 49.00% | Pass |
| Accounts receivable | 1.95% | 49.00% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.32% | 33.33% | Pass |
| Cash + interest-bearing securities | 3.55% | 33.33% | Pass |
| Accounts receivable | 5.50% | 49.00% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 37.10 | NEUTRAL |
| Stochastic %K (14) | 11.72 | BUY |
| CCI (20) | -150.69 | BUY |
| Williams %R (14) | -88.28 | BUY |
| MACD (12,26,9) | -0.12 | SELL |
| ROC (10) | -4.01 | SELL |
| Momentum (10) | -1.44 | SELL |
| EMA (10) | 35.25 | SELL |
| SMA (10) | 35.27 | SELL |
| EMA (20) | 35.81 | SELL |
| SMA (20) | 35.82 | SELL |
| EMA (30) | 36.14 | SELL |
| SMA (30) | 36.83 | SELL |
| EMA (50) | 36.58 | SELL |
| SMA (50) | 36.70 | SELL |
| EMA (100) | 38.03 | SELL |
| SMA (100) | 37.39 | SELL |
| EMA (200) | 42.08 | SELL |
| SMA (200) | 41.25 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Basic Materials · Specialty Chemicals
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers beauty and care products under brand Hymagic-VCHA VC Hylauronic Acid; Biomeet-MarineDNA; Bioyouth-SPG Schizophyllan Gel; Hymagic-GluHA; Bloomsurfact EncapCare RP; Bloomsurfact Sodium Surfactin; Hybloom Minitrue; Bioyouth-EGT Pure Ultrapure Ergothioneine; miniHA HA-Oligo degraded by hyaluronidase; microHA Super Active Hyaluronic Acid; Hymagic-AcHA Sodium Acetylated Hyaluronate; Hymagic-4D 4D Hyaluronic Acid; Hybloom Zinc Hyaluronate; Hybloom Sodium Hyaluronate 1% Solution; Hybloom Sodium Hyaluronate; Hybloom Oligo Hyaluronic Acid; Hybloom Low Molecular Weight Sodium Hyaluronate; Hybloom Hydrolyzed Hyaluronic Acid; Hybloom High Molecular Weight Sodium Hyaluronate; Hyanutra-RH Hair Nourishing Shield; Hyafacto-PGA Super High Molecular Weight Sodium Polyglutamate; Hyafactor-PGA Sodium Polyglutamate; Hyafactor-NAG Acetyl Glucosamine; Hyacross TG100 Hyaluronic Acid Elastomer; Hyacolor Oil-dispersed Sodium Hyaluronate; Gabacare BL98T Aminobutyric Acid; cationHA-G and clear Substantive Sodium Hyaluronate; Bioyouth-Natto Natto Extract; Bioyouth-NANA N-Acetylneuraminic Acid; Bioyouth HT Silky Hyaluronic Acid; Bioyouth-EGT Pro Super Active Ergothione; Bioyouth-Brice Brown Rice Ferment Filtrate; Bioyouth-FCM Cordyceps Militaris Ferment Filtrate; Bioyouth-EGT Ergothioneine Complex; Bioyouth BLC Bluelight Care; Bioecto Ectoine; Biobloom Microecobeauty. It also provides pharma and aesthetics; nutrition and health products under the brand Hyatrue; Bloomecto; Bloomcolla; BloomseaN; BloomStem; MitoEGT L-Ergothioneine; UltraHA J Sodium Hyaluronate; MitoPQQ Pyrroloquinoline Quinone Disodium; UltraHA-CWS Sodium Hyaluronate; HAPLEX Plus Sodium Hyaluronate; Gabarelax Gamma Aminobutyric Acid; UltraHA-GI-001 Special sodium hyaluronate for gut health; and Biovivid Collagen Peptide name. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.